Exact Mass: 258.1467

Exact Mass Matches: 258.1467

Found 110 metabolites which its exact mass value is equals to given mass value 258.1467, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

cyclo(dehydrophenylalanyl-L-leucyl)

Cyclo[(Z)-alpha,beta-didehydrophenylalanyl-L-leucyl]; (3Z,6S)-3-Benzylidene-6-(2-methylpropyl)piperazine-2,5-dione

C15H18N2O2 (258.1368)

2-Naphthylaminomethyl-gamma-aminobutyric acid

4-({[(naphthalen-2-yl)amino]methyl}amino)butanoic acid

C15H18N2O2 (258.1368)

Propoxate

Propyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid

C15H18N2O2 (258.1368)

5-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine

C14H19BN2O2 (258.154)

2-methyl-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole

C14H19BN2O2 (258.154)

2-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-INDAZOLE

C14H19BN2O2 (258.154)

3-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

C14H19BN2O2 (258.154)

tert-butyl 6-cyano-3,4-dihydroisoquinoline-2(1H)-carboxylate

C15H18N2O2 (258.1368)

METHYL 1-CYCLOHEXYL-1H-BENZO[D]IMIDAZOLE-5-CARBOXYLATE

C15H18N2O2 (258.1368)

Methyl 1-cyclohexyl-1H-benzo[d]imidazole-6-carboxylate

C15H18N2O2 (258.1368)

2-[(4-methylpiperazin-1-yl)methyl]-1H-quinazolin-4-one

C14H18N4O (258.1481)

3-AMINO-3-(4-DIMETHYLAMINO-NAPHTHALEN-1-YL)-PROPIONIC ACID

C15H18N2O2 (258.1368)

3-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine

C14H19BN2O2 (258.154)

2-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrrolo[2,3-b]pyridine

C14H19BN2O2 (258.154)

1-METHYL-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDAZOLE

C14H19BN2O2 (258.154)

DI-TERT-BUTYL 1,3-ACETONEDICARBOXYLATE

C13H22O5 (258.1467)

2,5-DIMETHYL-1,1:4,1-TERPHENYL

C20H18 (258.1408)

ETHYL 1-(4-CYANOPHENYL)-4-PIPERIDINECARBOXYLATE

C15H18N2O2 (258.1368)

(3,4-Dimethoxybenzyl)pyridin-4-ylmethylamine

C15H18N2O2 (258.1368)

Benzene,1,1,1-(1-ethanyl-2-ylidene)tris-

C20H18 (258.1408)

(4aS-cis)-4,4a,5,6,7,8-Hexahydro-1,4a-dimethyl-7-(1-methylethenyl)-2(3H)-naphthalenone

C15H18N2O2 (258.1368)

3a,4,5,6,7,7a-hexahydro-2-benzofuran-1,3-dione,2,2-dimethylpropane-1,3-diol

C13H22O5 (258.1467)

4-[(E)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethenyl]benzaldehyde

C15H19BO3 (258.1427)

Ethyl 1-phenyl-5-propyl-1H-pyrazole-4-carboxylate

C15H18N2O2 (258.1368)

2-methyl-7-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole

C14H19BN2O2 (258.154)

3-formyll-trans-beta-styrylboronic acid pinacol ester

C15H19BO3 (258.1427)

4,4-(1,3-Propanediyl)dioxydianiline

C15H18N2O2 (258.1368)

1-methyl-5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

C14H19BN2O2 (258.154)

2-methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-indazole

C14H19BN2O2 (258.154)

7-BENZYL-1,4-DIOXA-7-AZASPIRO[4.5]DECANE-8-CARBONITRILE

C15H18N2O2 (258.1368)

7-BENZYL-2,7-DIAZASPIRO[4.5]DECANE-1,3-DIONE

C15H18N2O2 (258.1368)

Pentalene, 1,3a,4,6a-tetrahydro-3,6-diphenyl-, (3aR,6aR)

C20H18 (258.1408)

2-Benzyl-2,8-diazaspiro[4.5]decane-1,3-dione

C15H18N2O2 (258.1368)

1-Butylpyrene

C20H18 (258.1408)

SORT-PGRN interaction inhibitor 1

C15H18N2O2 (258.1368)

(3AS,4R,6R,7AS)-TETRAHYDRO-4-HYDROXYMETHYL-6-METHOXY-4H-FURO[3,2-C]PYRAN-2(3H)-ONE

C15H18N2O2 (258.1368)

1-propan-2-yl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid

C15H18N2O2 (258.1368)

Triamterene D5

C12H6D5N7 (258.139)

1,8-DIPHENYL-1,3,5,7-OCTATETRAENE

C20H18 (258.1408)

N-[(1S)-4-Cyano-2,3-dihydro-1H-inden-1-yl]carbamic acid 1,1-dimethylethyl ester

C15H18N2O2 (258.1368)

tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate

C13H22O5 (258.1467)

(S)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate

C15H18N2O2 (258.1368)

Heptandioic acid, 4-acetyl-, 1,7-diethyl ester

C13H22O5 (258.1467)

1-methyl-6-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

C14H19BN2O2 (258.154)

Ethane, 1,1,1-triphenyl-

C20H18 (258.1408)

6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2,3-DIHYDROINDEN-1-ONE

C15H19BO3 (258.1427)

3-(1-BENZYL-3,5-DIMETHYL-1 H-PYRAZOL-4-YL)-PROPIONIC ACID

C15H18N2O2 (258.1368)

(3aS,6aS)-3,6-diphenyl-1,3a,4,6a-tetrahydropentalene

C20H18 (258.1408)

1,2-Bis-(1H-inden-3-yl)-ethane

C20H18 (258.1408)

(2,3-DIMETHOXY-BENZYL)-PYRIDIN-3-YLMETHYL-AMINE

C15H18N2O2 (258.1368)

Propoxate

propyl 3-(1-phenylethyl)imidazole-4-carboxylate

C15H18N2O2 (258.1368)

C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic

(3Z)-3-benzylidene-6-(2-methylpropyl)piperazine-2,5-dione

C15H18N2O2 (258.1368)

1-(1H-benzimidazol-2-yl)-3-cyclohexylurea

C14H18N4O (258.1481)

N-[4-(diethylamino)phenyl]furan-2-carboxamide

C15H18N2O2 (258.1368)

(4-Methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone

C15H18N2O2 (258.1368)

1-[5-Amino-3-(2-methylphenyl)-1,2,4-triazol-1-yl]-2,2-dimethylpropan-1-one

C14H18N4O (258.1481)

Alanylproline, TMS derivative

C11H22N2O3Si (258.14)

2-(4-Methylphenyl)-4,4-dimethyltetrahydropyrrolo[3,4-c]pyrrole-1,3(2H,5H)-dione

C15H18N2O2 (258.1368)

Ethyl (4R,5R)-(E)-5-hydroxy-4-(2-tetrahydropyranyl)oxy-2-hexenoate

Ethyl (4R*,5R*)-(E)-5-hydroxy-4-(2-tetrahydropyranyl)oxy-2-hexenoate

C13H22O5 (258.1467)

7,8-dihydroxy-4-methoxy-10-propyl-3,4,7,8,9,10-hexahydrooxecin-2-one

C13H22O5 (258.1467)

(13e)-1-amino-13-(2-hydroxyethylidene)-11-methyl-6-azatricyclo[7.3.1.0²,⁷]trideca-2,4,6,10-tetraen-5-ol

C15H18N2O2 (258.1368)

6β-hydroxyhuperzine a

C15H18N2O2 (258.1368)

{"Ingredient_id": "HBIN012276","Ingredient_name": "6\u03b2-hydroxyhuperzine a","Alias": "NA","Ingredient_formula": "C15H18N2O2","Ingredient_Smile": "CC=C1C2C=C(CC1(C3=C(C2O)NC(=O)C=C3)N)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10169","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}